Published in Am J Epidemiol on January 01, 1977
Associations between smoking and body weight in the US population: analysis of NHANES II. Am J Public Health (1987) 3.44
Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ (1989) 2.96
Smoking and weight: the Minnesota Lipid Research Clinic. Am J Public Health (1981) 1.70
The interaction of cigarette smoking, oral contraceptive use, and cardiovascular risk factor variables in children: the Bogalusa Heart Study. Am J Public Health (1982) 1.65
A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet (2002) 1.46
Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet (1988) 1.42
High-density lipoprotein concentrations increase after stopping smoking. Br Med J (Clin Res Ed) (1982) 1.27
Relationship between diet and smoking--is the diet of smokers different? J Epidemiol Community Health (1991) 1.26
Serum cholesterol and primary brain tumours: a case-control study. Br J Cancer (1985) 1.20
The prevalence of hypertension, obesity and dyslipidemia in individuals of over 30 years of age belonging to minorities from the pasture area of Xinjiang. BMC Public Health (2010) 1.16
Factors associated with higher body mass index, weight concern, and weight gain in a multinational cohort study of smokers intending to quit. Int J Environ Res Public Health (2009) 1.13
What determines mortality risk in male former cigarette smokers? Am J Public Health (1994) 1.07
Determinants of high density lipoprotein and total cholesterol in women. J Epidemiol Community Health (1982) 0.99
Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study. Nephrol Dial Transplant (2011) 0.97
The influence of smoking cessation on body weight may be temporary. Am J Public Health (1993) 0.94
Does Smoking Act as a Friend or Enemy of Blood Pressure? Let Release Pandora's Box. Cardiol Res Pract (2011) 0.91
Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes. Intern Emerg Med (2016) 0.86
Effect of Smoking on Blood Pressure and Resting Heart Rate: A Mendelian Randomization Meta-Analysis in the CARTA Consortium. Circ Cardiovasc Genet (2015) 0.82
Effect of thought suppression on desire to smoke and tobacco withdrawal symptoms. Psychopharmacology (Berl) (2011) 0.81
Blood flow velocity in the extraocular vessels in chronic smokers. Br J Ophthalmol (1997) 0.81
Interrelations among smoking habits, casual blood pressure and intraocular pressure in middle and old-aged Japanese residents. Environ Health Prev Med (2002) 0.77
Pharmacological measures to increase HDL-C among high risk isolated low HDL cases: a randomized study amongst north Indians. Indian J Med Res (2013) 0.75
Is there a connection between carbon monoxide exposure and hypertension? Environ Health Perspect (1991) 0.75
Blood lipid variability in relation to relative weight and biochemical markers of tobacco and alcohol consumption. Postgrad Med J (1985) 0.75
Risk of acute gout among active smokers: data from nationwide inpatient sample. Clin Rheumatol (2016) 0.75
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Illuminating the 'black box'. A description of 4454 patient visits to 138 family physicians. J Fam Pract (1998) 4.70
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA (1998) 3.37
In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men. Circulation (1991) 2.13
Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Cardiovasc Drugs Ther (1998) 2.01
Self-reported physical activity predicts long-term coronary heart disease and all-cause mortalities. Twenty-one-year follow-up of the Israeli Ischemic Heart Disease Study. Arch Fam Med (1995) 1.96
Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol (1997) 1.76
High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study. Am J Epidemiol (1979) 1.75
Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology (2004) 1.70
Long-term prognosis of women after myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am J Epidemiol (1997) 1.62
Major factors in the development of diabetes mellitus in 10,000 men. Arch Intern Med (1975) 1.62
Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees. A 23-year mortality follow-up in the Israeli Ischemic Heart Disease Study. Cardiology (1993) 1.60
Does diuretic therapy increase the risk of renal cell carcinoma? Am J Cardiol (1999) 1.60
Angina pectoris among 10,000 men. II. Psychosocial and other risk factors as evidenced by a multivariate analysis of a five year incidence study. Am J Med (1976) 1.58
The periodic health examination of older adults: the recommendations of the U.S. Preventive Services Task Force. Part II. Screening tests. J Am Geriatr Soc (1990) 1.58
Voluntary and involuntary weight loss: associations with long term mortality in 9,228 middle-aged and elderly men. Am J Epidemiol (1998) 1.56
Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up. Cardiology (1999) 1.52
Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect. Br Med J (Clin Res Ed) (1985) 1.44
Health and function in the old and very old. J Am Geriatr Soc (1988) 1.43
Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel. A comparison between 1981-1983 and 1992-1994. For the SPRINT and the Israeli Thrombolytic Survey Groups. Eur Heart J (2000) 1.43
Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease. J Am Coll Cardiol (1999) 1.42
Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality. The SPRINT Study Group. Ann Intern Med (1992) 1.41
The periodic health examination of older adults: the recommendations of the U.S. Preventive Services Task Force. Part I. Counseling, immunizations, and chemoprophylaxis. J Am Geriatr Soc (1990) 1.41
Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke (1996) 1.41
Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients. J Am Coll Cardiol (1996) 1.40
Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group. J Am Coll Cardiol (1998) 1.40
An epidemiologic investigation of hypertension and ischemic heart disease within a defined segment of the adult male population of Israel. Isr J Med Sci (1968) 1.30
Diabetes, prediabetes and uricaemia. Diabetologia (1976) 1.29
Factors related to diabetes incidence: a multivariate analysis of two years observation on 10,000 men. The Israel Ischemic Heart Disease Study. J Chronic Dis (1971) 1.28
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Uric acid and diabetes: observations in a population study. Lancet (1982) 1.24
Five-year myocardial infarction incidence. II. Association of single variables to age and birthplace. J Chronic Dis (1973) 1.22
Blood groups, myocardial infarction and angina pectoris among 10,000 adult males. N Engl J Med (1971) 1.22
The family life cycle and its implications for family practice. J Fam Pract (1979) 1.21
Family determinants of disease. I. General principles and concepts. Fam Pract (1984) 1.18
Patient perceptions of humanism in physicians: effects on positive health behaviors. Fam Med (1991) 1.16
Genetic aspects of arteriosclerosis. Arteriosclerosis (1986) 1.16
Comprehensive follow-up of carcinoma patients. J Chronic Dis (1971) 1.15
Unrecognized myocardial infarction: five-year incidence, mortality, and risk factors. Ann Intern Med (1976) 1.13
Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) Registry. Circulation (1999) 1.13
The epidemiology of coronary heart disease in the ethnically and culturally diverse population of Israel. A review. Isr J Med Sci (1982) 1.13
High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study. Stroke (1997) 1.12
Weight-height indices. Choice of the most suitable index and its association with selected variables among 10,000 adult males of heterogeneous origin. Br J Prev Soc Med (1974) 1.12
Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. SPRINT Study Group. Eur Heart J (1992) 1.11
Diabetes mellitus among 10,000 adult men. I. Five-year incidence and associated variables. Isr J Med Sci (1974) 1.11
The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. J Clin Epidemiol (1995) 1.08
The incidence of hypertension and associated factors: the Israel ischemic heart disease study. Am Heart J (1972) 1.06
Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor. Circulation (2001) 1.05
Random repeat 24-hour dietary recalls. Am J Clin Nutr (1971) 1.04
Antihypertensive therapy and the risk of malignancies. Eur Heart J (2001) 1.04
Circadian variation and possible external triggers of onset of myocardial infarction. SPRINT Study Group. Am J Med (1993) 1.04
Malignant arrhythmias in relation to values of serum potassium in patients with acute myocardial infarction. Int J Cardiol (1991) 1.04
Characteristics of smokers, nonsmokers and ex-smokers among 10,000 adult males in Israel. I. Distribution of selected sociodemographic and behavioral variables and the prevalence of disease. Isr J Med Sci (1975) 1.03
Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am Heart J (1997) 1.03
Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study Group. Am J Med (1992) 1.02
Congenital dislocation of the hip--a clinical-epidemiological study, Jerusalem 1954 to 1960. I. Retrospective incidence study. Isr J Med Sci (1966) 1.01
The frequency of sexual problems among family practice patients. Fam Pract Res J (1988) 1.01
Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men. Br J Ophthalmol (1983) 0.99
Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group. Am J Med (1993) 0.99
Myocardial infarction over a five-year period. I. Prevalence, incidence and mortality experience. J Chronic Dis (1973) 0.99
Serum uric acid: correlation with biochemical, anthropometric, clinical and behavioral parameters in 10,000 Israeli men. J Chronic Dis (1980) 0.98
Arterial enlargement in the atherosclerosis risk in communities (ARIC) cohort. In vivo quantification of carotid arterial enlargement. The ARIC Investigators. Stroke (1994) 0.98
Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group. Am J Cardiol (1996) 0.97
Differences in cardiovascular morbidity and mortality between previously known and newly diagnosed adult diabetics. Diabetologia (1977) 0.97
Complete atrioventricular block complicating inferior acute wall myocardial infarction: short- and long-term prognosis. Am Heart J (1993) 0.97
Enhanced risk of coronary heart disease mortality in lean hypertensive men. Hypertension (1987) 0.97
Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group. Arterioscler Thromb Vasc Biol (1996) 0.96
Are lean smokers at increased risk of lung cancer? The Israel Civil Servant Cancer Study. Arch Intern Med (1996) 0.95
Adult-onset diabetes among Arabs and Jews in Israel: a population-based study. Diabet Med (2012) 0.94
High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal? Arch Intern Med (2000) 0.94
Clinical myocardial infarction over a five-year period--III. A multivariate analysis of incidence, the Israel ischemic heart disease study. J Chronic Dis (1975) 0.94
A family epidemiological model: a practice and research concept for family medicine. J Fam Pract (1981) 0.94
Angina pectoris among 10,000 men. 5 year incidence and univariate analysis. Am J Med (1973) 0.92
The development of a dietary questionnaire for an ischemic heart disease survey. Isr J Med Sci (1968) 0.92
Correlation of weight-height index with diastolic and with systolic blood pressure. Br J Prev Soc Med (1970) 0.92
Association between metabolic syndrome, diabetes mellitus and prostate cancer risk. Prostate Cancer Prostatic Dis (2013) 0.91
Coronary heart disease: genetic aspects. Circulation (1983) 0.90
Meeting the challenge of research in family medicine: report of The Study Group on Family Medicine Research. J Fam Pract (1982) 0.90